Text Size
- News Releases
- What's New
- 19 Feb
- Chugai in-licenses New Oral Drug Candidate for COVID-19 from Roche
- 17 Feb
- Chugai Refiles Patent Infringement Lawsuit concerning Edirol Capsules
- 16 Feb
- Chugai Obtains Approval for Use of FoundationOne CDx Cancer Genomic Profile as a Companion Diagnostic for Pemigatinib for Patients with FGFR2 Fusion Positive Biliary Tract Cancer
- 12 Feb
- Chugai Wins the Grand Prize for the Third Time in the 23rd NIKKEI Annual Report Awards
- 09 Feb
- Results of Phase III Clinical Study in Japan for Actemra in COVID-19 Associated Pneumonia
Video Introduction of CHUGAI- Share this site
